Chromosomal breakage in myelodysplastic syndrome

Asian Pacific Journal of Cancer Prevention

Volumn 9, Issue 1, 2008, Pages 151-154

  Korgaonkar, Seema ^a   Babu, Rao V ^a   Kerketta, Lily ^a   Ghosh, Kanjaksha ^a  

^a NATIONAL INSTITUTE OF IMMUNOHAEMATOLOGY   (India)

Author keywords

Breakage; Chromosome aberrations; Fanconi anemia; Myelodysplastic syndrome; Occupational exposure

Indexed keywords

ALKYLATING AGENT; MITOMYCIN;

ARTICLE; BLAST CELL CRISIS; BLOOD; CHROMOSOME BANDING PATTERN; CHROMOSOME BREAKAGE; FANCONI ANEMIA; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; INDIA; KARYOTYPING; MYELODYSPLASTIC SYNDROME;

ALKYLATING AGENTS; BLAST CRISIS; CHROMOSOME BANDING; CHROMOSOME BREAKAGE; FANCONI ANEMIA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INDIA; KARYOTYPING; MITOMYCIN; MYELODYSPLASTIC SYNDROMES;

EID: 58349095053     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ahmed M M, Bhardwaj TPR, Sethuram S, et al (1993). Analysis of karyotype, SCE and point mutation of RAS oncogene in Indian MDS patients. Cancer Genet Cytogenet, 65, 12-20.
2. Ayraud N, Donzeau M, Raynaud S, et al (1983) Cytogenetic study of 88 cases of refractory anemia. Cancer Genet Cytogenet, 8, 243-8.
3. Bennett JM, Catovsky D, Daniel MT, et al (1983). Proposals for the classification of the myelodysplastic syndrome. Br J Haematol, 51, 189-99.
4. Farrow A, Jacob, West RR (1989). Myelodysplasia, chemical exposure and other environmental factors. Leukemia, 3, 33-5.
5. Gold EJ, Conjalka M, Pelus LM, et al (1983). Marrow cytogenetics and cell culture analysis of the myelodysplastic syndrome: Insight to pathophysiology and prognosis. J Clin Oncol, 1, 627-34.
6. Goldberg H, Lusk E, Moore J, et al (1990). Survey of exposure to genotoxic agents in primary myelodysplastic syndrome - correlation with chromosomes pattern and data in patients without haematological disease. Cancer Res, 50, 6876-81.
7. Gyger M, Infant-Rivard C, D'Angelo G, et al (1988). Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes. Am J Hematol, 28, 13-20.
8. Horke S, Taniwaki M, Misawa S, et al(1988). Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis. Cancer, 62, 1129-38.
9. Ido M, Nagata C, Kawqkami N, et al (1996). A case control study of myelodysplastic syndromes among Japanese Men and Women. Leuk Res, 20, 727-31.
10. Jacob RH, Carnbleet MA, Vardiman JW, et al (1986). Prognostic implications of morphology and Karyotype in primary myelodysplastic syndromes. Blood, 1, 1765-72.
11. Kadam P, Dadabhoy K, Bhisey A, et al (1995). Chromosome investigations and clinical outcome in patients with myelodysplastic syndromes. Indian J Med Res, 101, 163-9.
12. Knapp RH, Dewald GW, Pierre RV (1985). Cytogenetic studies in 174 consecutive patients with preleukaemic or myelodysplastic syndromes. Mayo Clin Proc, 60, 507-16.
13. Larripa I, Label de vinnesa M, Bengio R, et al (1987). Chromosome studies in human haematologic disease: II. Myelodysplastic syndromes Haematologica, 72, 399-403.
14. Le Beau MM, Onley HJ (2001). The cytogenetics of myelodysplastic syndromes. Best Pract Res Clin Haematol, 14, 479-95.
15. Lensch MW, Tischkowitz M, Christianson TA, et al (2003). Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukaemia. Blood, 102, 7-16.
16. Levine EG, Bloomfield CD (1992). Leukaemia and myelodysplastic syndromes secondary to drugs, radiation and environmental exposure. Seminars in oncology, 19, 47-84.
17. Muslilova J, Michalova K (1988). Chromosomes of 65 patients with myelodysplastic syndrome. Cancer Genet Cytogenet, 33, 39-50.
18. Nisse C, Haguenoer JM, Grandbastein B, et al (2001). Occupational and environmental risk factors of the myelodysplastic syndromes in the North France. Br J Haematol, 111, 927-35.
19. Pierre RV, Catovsky D, Muft GJ, et al (1989). Clinical cytogenetic correlations in myelodysplasia (preleukemia). Cancer Genet Cytogenet, 45, 149-61.
20. Third MIC cooperative study group Morphologic Immunologic and Cytogenetic (MIC) working classification of the primary myelodysplastic syndromes and therapy related myelodysplasias and leukaemias, 1987. Cancer Genet Cytogenet, 32, 1-10.
21. Vogel VG, Fisher RE, 193. Epidemiology and biology of leukaemia. Curr Opin Oncol, 5, 26-30.
22. West R, Stafford DA, Farrow A, et al 1995. Occupational and environmental exposures and myelodysplasia: a case control study. Leuk Res, 19, 127-39.
23. Yunis JJ, Lobell M, Arnesan MA, et al (1988). Refined study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogeneous leukaemia. Br J Haematol, 68, 189-94.